In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including:
Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedules
Available pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulations
Current and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerations
Presenters:
Kelly Romo, PharmD, BCOP Manager, Oncology Medical Drug Management and Customer Initiatives Blue Cross Blue Shield Michigan Detroit, Michigan
Shawna Kraft, PharmD, BCOP Clinical Pharmacist, Specialist Michigan Medicine, Rogel Cancer Center Clinical Associate Professor University of Michigan College of Pharmacy Ann Arbor, Michigan
Resources: Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Podden och tillhörande omslagsbild på den här sidan tillhör
ProCE. Innehållet i podden är skapat av ProCE och inte av,
eller tillsammans med, Poddtoppen.
